Joel Skoletsky

12 papers receiving 1.7k citations

Joel Skoletsky's Hit Papers

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin 2020 · 265 citations
2650+2+4Years since publication50100150200250

Peers

Joel Skoletsky
Comparison fields: 5 of 108
  • Pathology and Forensic Medicine 635
  • Cancer Research 462
  • Oncology 760
  • Pulmonary and Respiratory Medicine 457
  • Molecular Biology 702
Replace Klaske A. ten Hoor with:
Klaske A. ten Hoor Netherlands
Erika M. Kwon United States
Catherine Lofton–Day United States
Yanxin Luo China
Amy M. Fowler United States
Cindy A. Eads United States
Angelica A. Saetta Greece
Manuel Sánchez‐Chapado Spain
Karey Shumansky Canada
Victoria Wang United States
Joel Skoletsky relative to Klaske A. ten Hoor Netherlands Klaske A. ten Hoor's profile →
Citations per field
00.5×1.5×2.3×
Klaske A. ten Hoor · 1×
Citations per year

Countries citing papers authored by Joel Skoletsky

Since Specialization
Citations

This map shows the geographic impact of Joel Skoletsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Skoletsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Skoletsky more than expected).

Fields of papers citing papers by Joel Skoletsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Skoletsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Skoletsky. The network helps show where Joel Skoletsky may publish in the future.

Co-authors

The 25 scholars most cited alongside Joel Skoletsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joel Skoletsky Line = papers co-authored together Joel Skoletsky links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 2000399
2 1993343
3 2005283
4
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Hit paper breakdown →
2020265
5 2006192
6 199383
7 200459
8 199753
9 199646
10 202211
11 20204
12 20181
13 20250

About Joel Skoletsky

Joel Skoletsky is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology, Cancer Research and Molecular Biology, having authored 13 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Cystic Fibrosis Research Advances (3 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Screening and Detection (3 papers), Cancer Treatment and Pharmacology (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (635 citations), Cancer Research (462 citations), Oncology (760 citations), Pulmonary and Respiratory Medicine (457 citations) and Molecular Biology (702 citations). Joel Skoletsky has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Anthony P. Shuber, Kevin A. Boynton, David A. Ahlquist, William E. Pierceall, Jonathan J. Harrington, Douglas W. Mahoney, Stephen N. Thibodeau, K. Klinger, Brenda Richards and Henry L. Dorkin. Their work appears in journals such as Human Molecular Genetics, PLoS ONE, Cancer Research, JNCI Journal of the National Cancer Institute and Molecular Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact